Aarkstore - PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

1
Aarkstore - PharmaSphere Emerging
Biotechnologies - Stem Cell Therapy
Category Pharmaceuticals and Healthcare
2
Summary
"PharmaSphere Emerging Biotechnologies - Stem
Cell Therapy", provides strategic analysis of the
global stem cells industry. It discusses key
development trends, regulatory requirements in
various markets, recent deals activity and
industry dynamic trends, as well as describes the
operations strategy of these companies.
Furthermore, it includes a geographical
segmentation of various markets including the EU
and US, as well as emerging markets such as
China, India, SouthKorea, and Israel-providing
in-depth analysis of these markets regulatory
framework, key domestic players and their stem
cell pipelines, and strategic outlook. Throughout
the report, GlobalDatas analysts provide you with
expert insight, expanding on each strategy and
factor discussed, with the aim of providing you
with the tools needed for making informed
business decisions.
Browse Complete Report http//www.aarkstore.com
/pharmaceuticals-healthcare/62815/pharmasphere-eme
rging-biotechnologies-stem-cell-therapy
3
Highlights Key Questions Answered

• - (Q.) What are the key market drivers of the
  global stem cell industry?
• - (Q.) Who are the top players involved in the
  development of stem cell therapies in developed
  as well as developing countries?
• - (Q.) What are the main regulatory measures
  affecting the stem cell industry in the US,
  Europe, Japan, India, South Korea, China and
  Israel?
• - (Q.) What are the major trends in stem cell
  clinical trials and profiles of key
  investigators?
• - (Q.) What specific strategies are companies
  utilizing to combat some of the challenges
  currently facing the development of therapies in
  the global stem cell industry?

4
Scope

• - Stem Cell Market Dynamics This report provides
  analysis of the key drivers and trends shaping
  the global Stem Cell therapy market, including
  manufacturing, emerging markets, and development
  pipeline.
• - Financial Performance Insight Report uses
  GlobalDatas proprietary data across 22 key
  financial metrics to provide insight over stem
  cell company performance.
• - PipelineAnalysis Detailed information on ten
  leading stem cell therapies trend analysis of
  clinical trial studies and investigators covering
  over 1000 trials related to stem cell therapies.
• - Deal strategies Exhaustive discussion on the
  strategic implications and synergies of deals
  including, MA, collaboration as well as capital
  raisings such as equity offerings, private equity
  and venture financing activities.

5
Table of Content

• 1.1 List of Tables 14
• 1.2 List of Figures 19
• 2 Introduction 22
• 2.1 Report Scope 22
• 2.2 Upcoming Related Reports 24
• 2.3 Recently Published Reports 24
• 3 Stem Cell Overview 25
• 3.1 Definition 25
• 3.1.1 Renewal 25
• 3.1.2 Potency 25
• 3.2 Types of Stem Cell 26
• 3.2.1 Embryonic Stem Cells 27

6
List of Tables

• Table 1 Milestones in Stem Cell Research 29
• Table 2 Platform Technologies Adopted from
  Academic Institutions 43
• Table 3 Prochymal 44
• Table 4 Adult Autologous CD34 Stem Cells 45
• Table 5 StemEx 46
• Table 6 Allogeneic MPC For Bone Marrow
  Transplantation 47
• Table 7 Preob 48
• Table 8 Cerecellgram 49
• Table 9 Revascor 50
• Table 10 Tumor Stem Cell Specific Dendritic Cell
  Therapy 51
• Table 11 GSK-2696273 52
•  

7
List of Tables

• Table 1 Milestones in Stem Cell Research 29
• Table 2 Platform Technologies Adopted from
  Academic Institutions 43
• Table 3 Prochymal 44
• Table 4 Adult Autologous CD34 Stem Cells 45
• Table 5 StemEx 46
• Table 6 Allogeneic MPC For Bone Marrow
  Transplantation 47
• Table 7 Preob 48
• Table 8 Cerecellgram 49
• Table 9 Revascor 50
• Table 10 Tumor Stem Cell Specific Dendritic Cell
  Therapy 51
• Table 11 GSK-2696273 52
• Table 12 Lenti-D (Bluebird bio) 53
• Table 13 Highlighted MA Deals, January 1,
  2004-March 1, 2014 82

8
List of Figures

• Figure 1 Number of Unique Stem Cell Therapies
  Per Company 36
• Figure 2 Number of Stem Cell Therapy Indications
  Per Company (Top 27) 37
• Figure 3 Stem Cell Therapy Programs by Stage of
  Development 38
• Figure 4 Stem Cell Pipeline by Therapy Area 39
• Figure 5 Stem Cell Pipeline By Indication (Top
  31) 40
• Figure 6 Stem Cell Pipeline by Number of
  Indications Under Investigation 41
• Figure 7 Stem Cell Clinical Trials Annual Trend,
  2004-2014 55
• Figure 8 Stem Cell Clinical Trials by Phase of
  Development, 2004-March 1, 2014 56
• Figure 9 Stem Cell Clinical Trials by Status,
  January 1, 2004-March 1, 2014 57
• Figure 10 Stem Cell Clinical Trials by Therapy
  Area, January 1, 2004-March 1, 2014 58
• Figure 11 Stem Cell Clinical Trials Top 20
  Indications, January 1, 2004-March 1, 2014 59
• Figure 12 Stem Cell Clinical Trials Top 15
  Countries, January 1, 2004-March 1, 2014 60

9
Related reports

•  
• Essential Thrombocythemia - Pipeline Review, H1
  2015
• Oligodendroglioma - Pipeline Review, H1 2015
• Inclusion Body Myositis (IBM) - Pipeline Review,
  H1 2015
• Proliferative Diabetic Retinopathy (PDR) -
  Pipeline Review, H1 2015
• Chronic Inflammatory Demyelinating Polyneuropathy
  (CIDP) - Pipeline Review, H1 2015
• Fabry Disease-Pipeline Insights, 2015
• Ocular Hypertension-Pipeline Insights, 2015
• Shock-Pipeline Insights, 2015
• Fallopian Tube Cancer-Pipeline Insights, 2015

10

• PharmaSphere Emerging Biotechnologies - Stem
  Cell Therapy
• Published Nov 2014 248 Pages
• "PharmaSphere Emerging Biotechnologies - Stem
  Cell Therapy", provides strategic analysis of the
  global stem cells industry
• Price

Formats Price
PDF 2995
Site License 5990
Enterprise Wide License 8985
11
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news